PPARA and Alzheimer disease: PEA, an endogenous ALIAmide, has a proven ability to reduce reactive astrogliosis/microglial activation, suppress pro-inflammatory cytokines, and improve learning and memory in amyloid-based AD models via PPAR-α and related lipid-signaling targets [19,20,21].